Congress Is Likely to Approve Generic Drug User Fees: Action Should Spur Faster FDA Approvals

Podobne zapisy

• FDA Readies New Guidance and User Fee Program for Biosimilars: Drug interchangeability and user fees are contentious issues the FDA must resolve. Is the FDA up to the task?
  od: BARLAS, STEPHEN
  Wydane: (2012)
• Congress Readying User Fee Program for OTC Products: Money Needed to Dig FDA Out of Its Review Ditch
  od: Barlas, Stephen
  Wydane: (2018)
• Congress Passes Unambitious User Fee Reauthorization and Expansion: Act Omits Key Provisions Sought by Pharmacy Groups
  od: Barlas, Stephen
  Wydane: (2012)
• Over-the-Counter Products In Line for User Fee Program
  od: Barlas, Stephen
  Wydane: (2017)
• FDA Review of Drug Ads Doesn’t Add Up: Shortcomings Concern Congress
  od: Barlas, Stephen
  Wydane: (2008)